Webb12 apr. 2024 · Protalix BioTherapeutics Inc. (PLX) currently has a stock price of $2.50. The stock saw a sharp increase in the last trading session, hitting a high of $2.35 after opening at $2.30. The lowest recorded price for the day was $2.27 before it closed at $2.35. The stock market performance of Protalix BioTherapeutics Inc. has been very steady. WebbAlpha Galactosidase Market Size is projected to Reach Multimillion USD by 2030, In comparison to 2024, at unexpected CAGR during the forecast Period 2024-2030. Browse Detailed TOC, Tables and Figures with Charts which is spread across 114 Pages that provides exclusive data, information, vital statistics, trends, and competitive landscape …
Protalix BioTherapeutics Reports Fiscal Year 2024 Financial and ...
WebbPer-Share Earnings, Actuals & Estimates Protalix BioTherapeutics Inc. Quarterly Annual Actual Analyst Range Consensus 0.05 0.00 -0.05 -0.10 -0.15 PLX will report Q4 earnings on 05/10/2024... Webb8 apr. 2024 · Protalix BioTherapeutics Stock Performance. The firm has a market cap of $126.74 million, a PE ratio of -7.37 and a beta of 1.44. The stock’s 50 day simple moving … cool looping background
Home - Protalix Biotherapeutics
Webb10 apr. 2024 · Protalix BioTherapeutics Fair Value Forecast for 2024 - 2025 - 2030. In the last two years, Protalix BioTherapeutics's Price has grown, moving from $0.00 to $0.00 – … WebbGet the latest Protalix Biotherapeutics Inc (PLX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … WebbCARMIEL, Israel , Feb. 21, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical company focused on the development, … cool lots shorts